| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |